Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 3, 2005, Pages 497-501

  Paidas, Michael J ^a   Ku, D H W ^b   Lee, M J ^c   Manish, S ^c   Thurston, A ^a   Lockwood, C J ^a   Arkel, Y S ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Bio Reference Laboratory   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pregnancy complications; Protein S; Protein Z; Thrombophilia

Indexed keywords

ANTIGEN; FATTY ACID BINDING PROTEIN; PROTEIN S; PROTEIN S ANTIGEN; UNCLASSIFIED DRUG; PLASMA PROTEIN; PLASMA PROTEIN Z;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; PARITY; PLACENTA CIRCULATION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THROMBOPHILIA; BLOOD; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDY;

ADULT; BLOOD PROTEINS; FEMALE; GESTATIONAL AGE; HUMANS; PLACENTAL CIRCULATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; PROTEIN S; RISK FACTORS; THROMBOPHILIA;

EID: 21344437581     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01158.x     Document Type: Article

References (37)

1. Ghidini A, Salafia CM, Pezzullo JC. Placental vascular lesions and likelihood of diagnosis of pre-eclampsia. Obstet Gynecol 1997; 90: 542-5.
2. Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol 1995; 173: 1049-57.
3. Dekker GA, Sibai BM. Etiology and pathogenesis of pre-eclampsia: current concepts. Am J Obstet Gynecol 1998; 179: 1359-75.
4. Kupfermine MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 913.
5. Alfirevic Z. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002; 101: 6-14.
6. Infante-Rivard C. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002; 347: 19-25.
7. Roque H, Paidas MJ, Funai EF, Kuczynski E, Lockwood CJ. Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 2004; 91: 290-5.
8. Dizon-Townson D. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am J Obstet Gynecol 1997; 176: 883-6.
9. El-Bastawissi AY, Sorensen TK, Akafomo CK, Frederick IO, Xiao R, Williams MA. History of fetal loss and other adverse pregnancy outcomes in relation to subsequent risk of preterm delivery. Matern Child Health J 2003; 7: 53-8.
10. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002; 99: 333-41.
11. Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986; 68: 881-5.
12. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995; 90: 725-7.
13. Sugimura M, Kobayashi T, Kanayama N, Terao T. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay. Semin Thromb Hemost 1999; 25: 497-502.
14. Prager NA, Abendschein DR, McKenzie CR, Eisenberg PR. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots. Circulation 1995; 92: 962-7.
15. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-70.
16. Van Wijnen M, Stam JG, Veer C, Meijers JCM, Reitsma PH, Bertina RM. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of PS. Thromb Haemost 1996; 76: 397-403.
17. Koppelman SJ, Hackeng TM, Sixma JJ, Bouma BN. Inhibition of intrinsic factor X activating complex by protein S. evidence for a specific binding of protein S to factor VIII. Blood 1995; 86: 1062-71.
18. Kemkes-Matthes B, Matthes KJ. Protein Z. Semin Thromb Hemost 2001; 5: 551-6.
19. Han X, Fiehler R, Broze GJ Jr. Characterization of the protein Z-dependent protease inhibitor. Blood 2000; 96: 3049-55.
20. Broze GJ Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost 200l; 86: 8-13.
21. Yurdakok M, Gurakan B, Ozbag E, Vigit S, Dundar S, Kirazli S. Plasma protein Z levels in healthy newborn infants. Am J Hematol 1995; 48: 206-7.
22. Miletich JP, Broze GJ Jr. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood 1987; 69: 1580-6.
23. Kemkes-Matthes B, Nees M, Kuhnel G, Matzdorff A, Matthes KJ. Protein Z influences the prothrombotic phenotype in factor V Leiden patients. Thromb Res 2002; 106: 183-5.
24. McColl MD, Deans A, Maclean P, Tait RC, Greer IA, Walker ID. Plasma protein Z deficiency is common in women with antiphospholipid antibodies. Br J Haematol 2003; 120: 913-14.
25. Vasse M, Guegan-Massardier E, Borg J-Y, Woimant F, Soria C. Frequency of protein Z deficiency in patients with ischemic stroke. Lancet 2001; 357: 933-4.
26. Wuillemin WA, Demarmels Biasiutti F, Mattle HP, Lammie B. Frequency of PZ deficiency in patients with ischemic stroke. Lancet 2001; 358: 840-1.
27. Gris JC, Quere I, Dechaud H, Mercier E, Pincon C, Hoffet M, Vasse M, Mares P. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002; 99: 2606-8.
28. Gamba G, Bertolino G, Montani N, Spedini P, Balduini CL. Bleeding tendency of un known origin and protein Z levels. Thromb Res 1998; 90: 291-5.
29. Bakketeig LS, Butte N, de Onis M, Kramer M, O'Donnell A, Prada JA, Hoffman HJ. Report of the IDECG Working Group on definitions, classifications, causes, mechanisms and prevention of IUGR. Eur J Clin Nutr 1998; 52 (Suppl. 1): S94-6.
30. Davey DA, MacGillivary I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-8.
31. Lowe TW, Cunningham FG. Placental abruption. Clin Obstet Gynecol 1990; 33: 406-13.
32. Lockwood CJ, Kuczynski E. Risk stratification and pathological mechanisms in preterm delivery. Paediatr Perinat Epidemiol 2001; 15 (Suppl. 2): 78-89.
33. Miletich JP, Broze GJ. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood 1987; 69: 1580-6.
34. Deffert C, Esteve F, Grimaux M, Gouault-Heilmann M. A direct, automated, immuno-turbidimetric assay of free protein S antigen in plasma. Blood Coagul Fibrinol 2001; 12: 137-41.
35. Gris JC, Amadio C, Mercier E, Lavigne-Lissalde G, Dechaud H, Hoffet M, Quere I, Amiral J, Dauzat M, Mares P. Anti- protein Z antibodies in women with pathologic pregnancies. Blood 2003; 101: 4850-2.
36. Paidas MJ, Ku DH, Lee MJ, Lockwood CJ, Arkel YS. Pregnant patients with thrombophilia and subsequent adverse pregnancy outcomes have a decreased first trimester response to thrombomodulin in an activated partial thromboplastin time (APTT) system. J Thromb Haemost 2004 May; 2: 840-1.
37. Gris JC, Mercier E, Quere II, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland ML, Dauzat M, Mares P. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004; 103: 3695-9.